Position in PFE
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$832,263
+$201,098 QoQ
Shares Held
29,639
+16.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TSG Advice Partners, LLC holds $8,211,429 across 8 Drug Manufacturers - General names. PFE ranks #5 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,248 | $2,987,412 | |
| 2 | ABBV |
AbbVie Inc.
|
5,826 | $1,267,096 | |
| 3 | JNJ |
Johnson & Johnson
|
4,479 | $1,094,846 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,145 | $856,428 | |
| 5 | PFE |
Pfizer Inc
This page
|
29,639 | $832,263 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,062 | $608,907 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,194 | $315,016 | |
| 8 | AMGN |
Amgen Inc
|
709 | $249,461 |
All Filings in PFE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $832,263 | 29,639 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $631,165 | 25,348 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||